Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human HIP1 ELISA Kit (AC2635)
Cat.#: ASET-1224
Specifications
Description Human HIP1 ELISA Kit allows for the in vitro quantitative determination of human HIP1 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.094 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.156-10 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2075 Human PROKR2 ELISA Kit (AC3486) Quantitative inquiry ASET-2051 Human Cx30 ELISA Kit (AC3462) Quantitative inquiry ASET-1496 Porcine Neuropeptide Y ELISA Kit (AC2907) Quantitative inquiry ASET-2150 Mouse Thrombospondin 1 ELISA Kit (AC3561) Quantitative inquiry ASET-1080 Human APLP2 ELISA Kit (AC2491) Quantitative inquiry ASET-1422 Mouse Ataxin 1 ELISA Kit (AC2833) Quantitative inquiry ASET-1399 Mouse alpha 2a Adrenergic Receptor ELISA Kit (AC2810) Quantitative inquiry ASET-2393 Mouse Wnt5a ELISA Kit (AC3804) Quantitative inquiry ASET-2331 Mouse 14-3-3 zeta ELISA Kit (AC3742) Quantitative inquiry ASET-2085 Mouse S1PR2 ELISA Kit (AC3496) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket